Said Belaaouad

QSAR, ADMET, molecular docking, and dynamics studies of 1,2,4-triazine-3(2H)-one derivatives as tubulin inhibitors for breast cancer therapy

Rachid Daoud, Soukayna Baammi, Achraf El Allali, 2024, Scientific reports.